NFE2L2 and epilepsy: Using transcription factor enrichment analysis (TFEA) on publically available gene expression data sets (using IPA software) from a variety of epilepsy-related studies (including animal epilepsy models and ketogenic diet-treated animals), Mazzuferi and coworkers [107] identified Nrf2 as one of the main transcription factors with a potential therapeutic use.